shenzhen salubris pharmaceuticals co., ltd.-凯发官网首页

news & trends

• 112023-01

  clinical trial approved! good news for sal0133 tablets

• 112023-01

  sal008 injection for the treatment of advanced solid tumors approved for clinical trial

• 112023-01

  the application for a clinical trial of sal0133 tablets for the treatment of mild/common covid-19 in adults was accepted

• 112023-01

  new clinical progress of sal003 for the treatment of hypercholesterolemia and mixed hyperlipidemia

• 112023-01

  two alliances for biomedicine and high-end medical devices established

• 242022-11

  ind acceptance by nmpa for sal0119 tablets for the treatment of active ankylosing spondylitis and moderate-to-severe active rheumatoid arthritis